Two main types of peginterferon-based regimens are currently available: alfa-2a and alfa-2b; which regimen is better is unknown. To address this issue, the IDEAL study team (supported by grants ...

Peginterferon alfa-2a is a form of recombinant interferon already indicated to treat chronic hepatitis B infection in people who show signs of liver damage. "Combining drugs with different target ...

PharmaEssentia (TWSE: 6446), a global biopharmaceutical company, reaffirms its enduring commitment to creating robust and reliable access to critical interferon therapies. Amidst growing global ...

placebo, P<0.001). Peginterferon therapy (with either interferon) was initiated in 49 patients. Although platelet counts dropped during peginterferon therapy, they remained consistently above ...